Atlas Trials

Biomarker Changes and Anxiolytic Effects-Phase 2

Clinical trial NCT04565145 · COMPLETED

Trial details

NCT number
NCT04565145
Sponsor
University of Florida
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pharmacokinetics
Start date
2021-04-05
Primary completion
2023-07-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.